Media headlines about RTI Surgical (NASDAQ:RTIX) have been trending somewhat positive on Friday, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. RTI Surgical earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 47.5666809989835 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

RTIX has been the subject of a number of research reports. BidaskClub downgraded RTI Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, August 8th. Zacks Investment Research downgraded RTI Surgical from a “hold” rating to a “sell” rating in a report on Thursday, October 5th.

Shares of RTI Surgical (RTIX) opened at $4.75 on Friday. RTI Surgical has a 12 month low of $2.81 and a 12 month high of $6.00. The company has a market capitalization of $288.95, a price-to-earnings ratio of 118.75, a PEG ratio of 6.33 and a beta of 1.73. The company has a quick ratio of 1.21, a current ratio of 3.34 and a debt-to-equity ratio of 0.25.

RTI Surgical (NASDAQ:RTIX) last released its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 EPS for the quarter, hitting analysts’ consensus estimates of $0.01. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The firm had revenue of $66.69 million for the quarter, compared to analysts’ expectations of $65.63 million. RTI Surgical’s quarterly revenue was up .2% on a year-over-year basis. equities research analysts anticipate that RTI Surgical will post 0.05 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact RTI Surgical (RTIX) Share Price” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/24/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-rti-surgical-rtix-share-price.html.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Insider Buying and Selling by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Stock Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related stocks with our FREE daily email newsletter.